🔎 Trials Near Me

Gara Jalqabaatti › Saree Bronchial › Illinois

Qorannoo klinikaalii Saree Bronchial Illinois keessatti

Qorannoo 5 Saree Bronchial f Illinois keessatti hirmaatuu jiru.

Magaalota Illinois keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Illinois at Chicago, Chicago
  • University of Chicago Hospital, Chicago
  • Springfield Clinic Main Campus, Springfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • Illinois Cancer Specialists, Arlington Heights
  • University of Illinois Hospital and Health Sciences Systems, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07185997

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Advocate Aurora Health, Park Ridge
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT04614103

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • University of Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Gur-2026 · NCT02984761

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.